United States · FDA National Drug Code directory
TOPIRAMATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-833_941c8d76-48bb-4f96-82d4-b39ffaa9df49
- Product NDC
- 67877-833
- Form
- SOLUTION
- Composition / generic term
- TOPIRAMATE
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250707
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE (67877-833-47) · 67877-833-47
- 1 BOTTLE in 1 CARTON (67877-833-61) / 120 mL in 1 BOTTLE · 67877-833-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →